Aviva’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Aviva’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17,400	Closed	-$283K	–	1078
2022 Q1	$283K	Buy	17,400 +2,700	+18%	+$69.2K	﹤0.01%	1050
2021 Q4	$697K	Buy	14,700 +3,000	+26%	+$180K	﹤0.01%	966
2021 Q3	$848K	Buy	11,700 +2,100	+22%	+$152K	﹤0.01%	943
2021 Q2	$806K	Buy	+9,600	New	+$633K	﹤0.01%	817

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aviva's NBP Position: Q2 2022 in Review

Aviva sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 17,400 shares — an estimated $283K sold.

Aviva first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $848K in Q3 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

Aviva reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Aviva sold 17,400 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $283K.
Aviva first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
Aviva's NovaBridge Biosciences American Depositary Shares position peaked at $848K in Q3 2021.
97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Aviva's 13F filing for Q2 2022, filed 4 Aug 2022.